Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Recursion Pharmaceuticals, Inc. - Class A Common Stock
(NQ:
RXRX
)
3.160
+0.010 (+0.32%)
Streaming Delayed Price
Updated: 3:13 PM EDT, Apr 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy
June 06, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
May 30, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
3 Monster Stocks to Hold for the Next 10 Years
↗
May 26, 2025
A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most.
Via
The Motley Fool
Topics
Energy
8 Health Care Stocks With Whale Alerts In Today's Session
↗
May 23, 2025
Via
Benzinga
Earnings Scheduled For May 5, 2025
↗
May 05, 2025
Via
Benzinga
These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio
May 22, 2025
While institutional money managers have released their Q1 holdings, so has the heart and soul of the AI revolution, NVIDIA. See which six stocks NVIDIA owns.
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip?
↗
May 12, 2025
Via
The Motley Fool
Topics
Animal Testing
Artificial Intelligence
2 Top Artificial Intelligence (AI) Stocks to Buy Right Now
↗
May 11, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Why Recursion Pharmaceuticals Stock Plummeted 24% This Week
↗
May 09, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Stocks
Why Recursion Pharmaceuticals Stock Is Plummeting Today
↗
May 06, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Stocks
Recursion to Participate in Upcoming Investor Conferences
May 06, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Why Recursion Pharmaceuticals Stock Was Getting Mashed on Monday
↗
May 05, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Recursion Reports First Quarter 2025 Financial Results and Provides Business Update
May 05, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Retail Traders Bearish On Recursion Pharma Ahead of Q1 Results Despite Positive Tupelo Trial Data
↗
May 04, 2025
Traders flagged a key technical level at $4.65 and raised concerns over an outlier patient in the Tupelo trial, with attention now turning to management’s commentary during the earnings call.
Via
Stocktwits
Topics
Earnings
Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden
May 04, 2025
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
How Do Investors Really Feel About Recursion Pharmaceuticals?
↗
May 01, 2025
Via
Benzinga
Recursion to Report First Quarter 2025 Business Updates and Financial Results on May 5th
April 28, 2025
Company to host public (L)earnings call on May 5th at 8:00 am ET / 6:00 am MT / 1:00 pm GMT
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:TEM),(NASDAQ:POAI),(NASDAQ:ADMA) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
3 Monster Stocks to Hold for the Next 10 Years
↗
April 23, 2025
They're not just leaders of their industry. Their underlying businesses are also on the verge of enormous growth.
Via
The Motley Fool
Global Artificial Intelligence Influence on Diabetic Retinopathy Market Expected to See Significant Growth
April 29, 2025
From
FN Media Group LLC
Via
GlobeNewswire
Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025
April 22, 2025
From
Recursion Pharmaceuticals
Via
GlobeNewswire
This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy?
↗
April 18, 2025
Via
The Motley Fool
Topics
Animal Testing
Artificial Intelligence
Intellectual Property
Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News
↗
April 15, 2025
Via
Stocktwits
Topics
Animal Testing
Artificial Intelligence
Stocks
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
↗
April 14, 2025
FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.
Via
Benzinga
Topics
Animal Testing
Top 3 Biotech Stocks That Got Retail Street Buzzing Last Week: SMMT, PTN, RXRX
↗
April 13, 2025
Positive expectations from key clinical trials, delisting fears and some regulatory changes triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11, 2025.
Via
Stocktwits
Topics
Animal Testing
These Mid-Cap Stocks Outshone The Market Volatility Last Week (Apr 7-Apr 11): Are These In Your Portfolio?
↗
April 13, 2025
Top mid-cap stock performers last week: AGL, RXRX, CERT, AVAV, STRL, ORLA, IAG, SBSW, LOAR, RYTM, TLX. High gains due to positive news and macro uncertainty.
Via
Benzinga
The market is filled with gapping stocks in Friday's session.
↗
April 11, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
Why Recursion Pharmaceuticals Stock Is Skyrocketing Today
↗
April 11, 2025
Via
The Motley Fool
Topics
Animal Testing
Artificial Intelligence
Recursion Pharmaceuticals Shares Are Up Today: what's Going On?
↗
April 11, 2025
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Friday after the U.S. Food and Drug Administration announced a significant policy change that could reshape the drug...
Via
Benzinga
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
↗
April 11, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
